StonvexLoading…
StonvexStonvexStonvexCore line items from IEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $914.58M | $886.90M | $3.46B | $2.56B | $1.68B |
Operating Income | Not available | $172.40M | $699.30M | $515.70M | $329.90M |
Net Income | Not available | $120.00M | $483.20M | $354.90M | $227.10M |
EPS (Diluted) | $2.13 | $1.61 | $6.41 | $4.70 | $3.00 |
Total Assets | Not available | $6.92B | $6.93B | $6.97B | $6.88B |
Total Liabilities | Not available | $2.87B | $2.90B | $2.96B | $2.87B |
Cash & Equivalents | Not available | $586.20M | $580.00M | $593.80M | $568.20M |
Free Cash Flow OCF − CapEx | Not available | $86.00M | $616.80M | $427.00M | $238.30M |
Shares Outstanding | Not available | 74.40M | 75.30M | 75.50M | 75.70M |